Article

Scientists try to find easier way to detect early diabetic retinopathy

Beams of light are being used as a less invasive, less expensive approach to spot early stages of retinal damage from diabetic retinopathy by measuring blood flow in the back of the eye, according to scientists in California.

Washington, DC-Beams of light are being used as a less invasive, less expensive approach to spot early stages of retinal damage from diabetic retinopathy by measuring blood flow in the back of the eye, according to scientists in California.

"The more severe the retinopathy, the lower the blood flow to the retina," said David Huang, MD, of the Keck School of Medicine, University of Southern California, Los Angeles.

According to the U.S. Centers for Disease Control and Prevention, 5.5 million people over the age of 40 suffered from this condition in 2005, and this number is expected to triple by 2050 as the number of people with diabetes continues to increase. Vision loss is preventable if retinal damage is detected early.

The scientists adapted optical coherence tomography (OCT)-normally used to take cross-sectional pictures of the retina-to detect directly the amount of blood flowing through retinal blood vessels.

Dr. Huang's research takes advantage of Interactive Science Publishing (ISP), an initiative undertaken by the Optical Society of America in partnership with the National Library of Medicine, part of the National Institutes of Health, and with the support of the U.S. Air Force Office of Scientific Research. For more information on ISP, visit www. opticsinfobase.org/isp.cfm.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.